Gynecologic Oncology

35071 Citations
67 h-index
286 Article
24 Review article
15 Comment/debate
11 Chapter
More

A case of perioperative and intraoperative management of a rare vaginal paraganglioma
Wetzler, S., Mercier, A. M., Maini, R., Sheskier, R., Craig, E., Liu, Y. & Zakashansky, K., Apr 2026, In: Gynecologic Oncology Reports. 64, 102044.
Research output: Contribution to journal › Article › peer-review

Open Access
A convergent uPAR-positive tumor ecosystem creates broad vulnerability to CAR T cell therapy
Zhang, Z., Ho, Y. J., Fang, X., Kim, M., Li, M., Luan, W., Hinterleitner, C., Haubner, S., Kogel, F., Pratt, E. C., Ozcelik, E., Reyes, J., Jiang, Q., Yang, V. W., Chen, Y. J., Wang, T., Liu, H., Hu, H., Zhuang, X. & Park, J. & 48 others, Paffenholz, S. V., Chen, K., Chang, Q., Kulick, A., Zhang, J., Chan, E., Rosiek, E., Fan, N., Williams, R. A., Wang, A. C., Freeman, S., Tian, S., Gunset, G., Garcia Angus, A., Lecomte, N., Yildirim, S. Y., Ali, E., Wu, M., Miranda, I. C., Antonescu, C. R., Basturk, O., Tarcan, Z., Rekhtman, N., Wilson, C., Basar, M., Sauter, J. L., Al-Ahmadie, H. A., Singer, S., Iacobuzio-Donahue, C., Rudin, C., de Stanchina, E., Ganesh, K., Romesser, P. B., Weigelt, B., Huh, D. D., Leibold, J., Feucht, J., Vázquez-García, I., Bott, M. J., Zamarin, D., Shah, S. P., Lewis, J. S., Amor, C., Pe’er, D., Mansilla-Soto, J., Filliol, A., Sadelain, M. & Lowe, S. W., 14 May 2026, In: Cell. 189, 10, p. 2898-2917.e42
Research output: Contribution to journal › Article › peer-review

Open Access
5 Scopus citations
Advances in immunotherapies in ovarian cancer
Ayasun, R. & Zamarin, D., 19 Jun 2026, In: Journal for ImmunoTherapy of Cancer. 14, 6
Research output: Contribution to journal › Review article › peer-review

Open Access
Can ChatGPT Take My Call? evaluating AI in gynecologic oncology telephone triage
Mercier, A. M., Holtzman, S., Saini, A., Mordell, L. J., Vallejo, A., Zeligs, K., Williams, S., Carr, C. & Blank, S. V., Jun 2026, In: Gynecologic Oncology Reports. 65, 102101.
Research output: Contribution to journal › Article › peer-review

Open Access
Correction: Inhibition of the Nuclear Export Receptor XPO1 as a Therapeutic Target for Platinum-Resistant Ovarian Cancer (Clin Cancer Res (2017), 23, (1552-1563), 10.1158/1078-0432.CCR-16-1333)
Chen, Y., Camacho, S. C., Silvers, T. R., Razak, A. R. A., Gabrail, N. Y., Gerecitano, J. F., Kalir, E., Pereira, E., Evans, B. R., Ramus, S. J., Huang, F., Priedigkeit, N., Rodriguez, E., Donovan, M., Khan, F., Kalir, T., Sebra, R., Uzilov, A., Chen, R. & Sinha, R. & 11 others, Halpert, R., Billaud, J. N., Shacham, S., McCauley, D., Landesman, Y., Rashal, T., Kauffman, M., Mirza, M. R., Mau-Sørensen, M., Dottino, P. & Martignetti, J. A., 15 Mar 2026, In: Clinical Cancer Research. 32, 6, p. 1183 1 p.
Research output: Contribution to journal › Comment/debate

Open Access
Cost and efficiency of universal versus selective next generation sequencing for advanced stage endometrial cancer
Bashi, A., Penvose, K. N., Wright, J. D., Blank, S. V., Albright, B. B., Hazelton, W. D., Rossi, E., Myers, E. R., Secord, A. A. & Havrilesky, L. J., Apr 2026, In: Gynecologic Oncology. 207, p. 67-73 7 p.
Research output: Contribution to journal › Article › peer-review
CRI-CCTG-0003/IND.240 an immunotherapy platform study in platinum-resistant high grade serous ovarian cancer (IPROC): Sub-studies A and B: Durvalumab (D) + mecbotamab vedotin (BA3011) or ozuriftamab vedotin (BA3021)
MacKay, H. J., Tinker, A. V., Nelson, B. H., Zamarin, D., Odunsi, A. O., Lheureux, S., Ellard, S., Smrke, A., Gaudreau, P. O., Faulkner, T., Upadhaya, S., Zhou, A., Tu, W. & Dancey, J., 2026, In: Cancer Treatment and Research Communications. 48, 101260.
Research output: Contribution to journal › Article › peer-review

Open Access
Endometrial Mixed and Mixed-Feature Carcinomas: Small Cohort Clinicopathologic and Molecular Studies
Bhardwaj, S., Saleh, M., Kinoshita, Y., Brody, R., Lukatskaya, O., Blank, S. V., Baskovich, B. & Kalir, T., Feb 2026, In: Cancers. 18, 3, 440.
Research output: Contribution to journal › Article › peer-review

Open Access
Endometrial thickness in patients with postmenopausal bleeding and endometrial cancer: A retrospective cohort study
Liu, J., Nolin, A. C., Unnithan, S., Erkanli, A., Penvose, K., Atkins, S., Holtzman, S., Chess, I., Vattakalam, A., Blank, S. V., Wright, J. D., Albright, B. B., Hazelton, W. D., Myers, E. R. & Havrilesky, L. J., Aug 2026, In: Gynecologic Oncology Reports. 66, 102135.
Research output: Contribution to journal › Article › peer-review

Open Access
Endorsing consensus interpretation for diagnosing placenta accreta spectrum disorders on MRI
Parnes, B., Kamath, A., Friedman, B., King, M., Lieberman, C., Ho, K., Ali, K., Platt, S., Sharma, H., Xiang, J., Rastegar, S., Liu, Y., Doucette, J., Zakashansky, K., Taouli, B. & Lewis, S., Jan 2026, In: European Radiology. 36, 1, p. 278-287 10 p.
Research output: Contribution to journal › Article › peer-review
1 Scopus citations
Maintenance therapy after first-line therapy for ovarian cancer: Quantitative effectiveness
Campos, S. M., DiSilvestro, J. & Blank, S. V., 1 Jan 2026, In: Ca-A Cancer Journal for Clinicians. 76, 1, e70057.
Research output: Contribution to journal › Editorial

Open Access
Navigating the healthcare system with a BRCA1/2 pathogenic variant: What do patients value?
Karimaghaie, T., Webster, E. M., Levi, S. R., Blank, S. V., Walsh, C., Rivera, L. B. D., Gilliland, J., Vanroboys, A., Kirby, M., Ahsan, M. D., Lopez, S., Sharaf, S., Epstein, E. S., Ellis, A. & Frey, M. K., Jun 2026, In: Gynecologic Oncology Reports. 65, 102104.
Research output: Contribution to journal › Article › peer-review

Open Access
1 Scopus citations

Duke University Reports Findings in Endometrial Cancer (Cost and Efficiency of Universal Versus Selective Next Generation Sequencing for Advanced Stage Endometrial Cancer)
Blank, S.
30/06/26
1 item of Media coverage
Press/Media
BioInvent to Host Virtual KOL Event to Discuss BI-1808 for the Treatment of Ovarian Cancer, on May 27, 2026
Zamarin, D.
20/05/26 → 22/05/26
21 items of Media coverage
Press/Media
BioInvent to Host Virtual KOL Event to Discuss BI-1808 for the Treatment of Ovarian Cancer, on May 27, 2026
Zamarin, D.
21/05/26
1 item of Media coverage
Press/Media
Researchers from Yale University School of Medicine Report Details of New Studies and Findings in the Area of Endometrial Cancer (Real World Outcomes of Pembrolizumab and Reduced-Dose Lenvatinib in Recurrent Endometrial Cancer by Platinum and ...)
Dottino, P.
15/05/26
1 item of Media coverage
Press/Media
BioInvent to Host Two Key Opinion Leader Events Highlighting Progress Across Oncology Portfolio
Zamarin, D.
9/05/26
1 item of Media coverage
Press/Media
Icahn School of Medicine at Mount Sinai Researchers Report Research in Stevens-Johnson Syndrome (Tisotumab vedotin-associated Stevens-Johnson syndrome in a patient with recurrent vulvar cancer: Vulnerability and antibody drug conjugate toxicity ...)
Blank, S. & Prasad-Hayes, M.
29/04/26
1 item of Media coverage
Press/Media
BioInvent to Host Two Key Opinion Leader Events Highlighting Progress Across Oncology Portfolio
Zamarin, D.
29/04/26
21 items of Media coverage
Press/Media
New Cancer Findings Reported from Icahn School of Medicine at Mount Sinai (Unnecessary exclusions: eligibility criteria in gynecologic oncology interventional clinical trials impairs access)
Blank, S., Zakashansky, K. & Zamarin, D.
21/04/26
1 item of Media coverage
Press/Media
Mount Sinai Researchers Highlight Advances in Cancer Science at 2026 AACR Annual Meeting in San Diego
Galsky, M., Wang, P., Parsons, R., Marron, T., Vabret, N., Bravo-Cordero, J. J., Gaire, B., Zamarin, D. & Wei, Y.
15/04/26 → 16/04/26
3 items of Media coverage
Press/Media
Data on Paragangliomas Reported by Researchers at Icahn School of Medicine at Mount Sinai (A case of perioperative and intraoperative management of a rare vaginal paraganglioma)
Zakashansky, K.
6/04/26
1 item of Media coverage
Press/Media
Cell Surface Protein uPAR May Hold the Key to Targeting Solid Tumors with CAR T Cell Therapy
Zamarin, D.
30/03/26
3 items of Media coverage
Press/Media
OverT Bio Announces the Formation of the Clinical Advisory Board to Support the Clinical Development of OVT-101 in Ovarian Cancer and Other Solid Tumors; OverT builds scalable, cost-effective immune therapies for solid tumors using its data-driven discove
Zamarin, D.
23/03/26 → 24/03/26
12 items of Media coverage
Press/Media

Gynecologic Oncology

Fingerprint

Collaborations and top research areas from the last five years

Dive into details

Stephanie Blank

Samantha Cohen

Peter Dottino

Gila Leiter

Nimesh Nagarsheth

Monica Prasad-Hayes

Konstantin Zakashansky

Dmitriy Zamarin

A case of perioperative and intraoperative management of a rare vaginal paraganglioma

A convergent uPAR-positive tumor ecosystem creates broad vulnerability to CAR T cell therapy

Advances in immunotherapies in ovarian cancer

Can ChatGPT Take My Call? evaluating AI in gynecologic oncology telephone triage

Correction: Inhibition of the Nuclear Export Receptor XPO1 as a Therapeutic Target for Platinum-Resistant Ovarian Cancer (Clin Cancer Res (2017), 23, (1552-1563), 10.1158/1078-0432.CCR-16-1333)

Cost and efficiency of universal versus selective next generation sequencing for advanced stage endometrial cancer

CRI-CCTG-0003/IND.240 an immunotherapy platform study in platinum-resistant high grade serous ovarian cancer (IPROC): Sub-studies A and B: Durvalumab (D) + mecbotamab vedotin (BA3011) or ozuriftamab vedotin (BA3021)

Endometrial Mixed and Mixed-Feature Carcinomas: Small Cohort Clinicopathologic and Molecular Studies

Endometrial thickness in patients with postmenopausal bleeding and endometrial cancer: A retrospective cohort study

Endorsing consensus interpretation for diagnosing placenta accreta spectrum disorders on MRI

Maintenance therapy after first-line therapy for ovarian cancer: Quantitative effectiveness

Navigating the healthcare system with a BRCA1/2 pathogenic variant: What do patients value?

Duke University Reports Findings in Endometrial Cancer (Cost and Efficiency of Universal Versus Selective Next Generation Sequencing for Advanced Stage Endometrial Cancer)

BioInvent to Host Virtual KOL Event to Discuss BI-1808 for the Treatment of Ovarian Cancer, on May 27, 2026

BioInvent to Host Virtual KOL Event to Discuss BI-1808 for the Treatment of Ovarian Cancer, on May 27, 2026

Researchers from Yale University School of Medicine Report Details of New Studies and Findings in the Area of Endometrial Cancer (Real World Outcomes of Pembrolizumab and Reduced-Dose Lenvatinib in Recurrent Endometrial Cancer by Platinum and ...)

BioInvent to Host Two Key Opinion Leader Events Highlighting Progress Across Oncology Portfolio

Icahn School of Medicine at Mount Sinai Researchers Report Research in Stevens-Johnson Syndrome (Tisotumab vedotin-associated Stevens-Johnson syndrome in a patient with recurrent vulvar cancer: Vulnerability and antibody drug conjugate toxicity ...)

BioInvent to Host Two Key Opinion Leader Events Highlighting Progress Across Oncology Portfolio

New Cancer Findings Reported from Icahn School of Medicine at Mount Sinai (Unnecessary exclusions: eligibility criteria in gynecologic oncology interventional clinical trials impairs access)

Mount Sinai Researchers Highlight Advances in Cancer Science at 2026 AACR Annual Meeting in San Diego

Data on Paragangliomas Reported by Researchers at Icahn School of Medicine at Mount Sinai (A case of perioperative and intraoperative management of a rare vaginal paraganglioma)

Cell Surface Protein uPAR May Hold the Key to Targeting Solid Tumors with CAR T Cell Therapy

OverT Bio Announces the Formation of the Clinical Advisory Board to Support the Clinical Development of OVT-101 in Ovarian Cancer and Other Solid Tumors; OverT builds scalable, cost-effective immune therapies for solid tumors using its data-driven discove

Gynecologic Oncology

Fingerprint

Collaborations and top research areas from the last five years

Profiles

Research output

Press/Media